The Latest in B Cell Lymphoma

Ibrutinib stacks up well on safety in pooled analysis

July 20, 2018

FDA grants UCB product orphan designation

July 18, 2018

B Cell Lymphoma

PET-guided treatment didn’t improve outcomes

July 16, 2018

B Cell Lymphoma

New guideline for managing MCL

July 13, 2018

Genentech submits sNDA for venetoclax in untreated AML

July 12, 2018

B Cell Lymphoma

Transplant strategy not viable for aggressive B-NHL

July 6, 2018

JAK inhibition linked to B-cell lymphoma

July 5, 2018

B Cell Lymphoma

‘Very encouraging’ results in BPDCN

July 3, 2018

B Cell Lymphoma

CHMP recommends CAR T for ALL, DLBCL

July 2, 2018

B Cell Lymphoma

CHMP recommends CAR T for DLBCL, PMBCL

July 2, 2018

European Medicines Agency recommends CAR T-cell approvals

June 29, 2018

B Cell Lymphoma

Bortezomib plus vorinostat shows modest response in MCL

June 29, 2018

Doc reports favorable results from trial on hold

June 29, 2018

CPI-613 receives orphan designation for BL

June 29, 2018

B Cell Lymphoma

CAR T in DLBCL: Liso-cel has ‘remarkable’ efficacy in cohort

June 27, 2018

B Cell Lymphoma